BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC
237 results:

  • 1. Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island.
    Li B; Chen X; Xian H; Wen Q; Wang T
    PeerJ; 2023; 11():e16392. PubMed ID: 38050610
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]    [Full Text] [Related]  

  • 3. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
    Ferreira AMC; Altemani JMC; Macedo LT; Lourenço GJ; Lima CSP
    Sci Rep; 2023 Oct; 13(1):16762. PubMed ID: 37798436
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
    Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
    J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
    AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
    Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
    Kovács SA; Fekete JT; Győrffy B
    Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma.
    Yamauchi T; Fujishima F; Tsunokake J; Kunimitsu A; Akaishi R; Ozawa Y; Fukutomi T; Okamoto H; Sato C; Taniyama Y; Kamei T; Ichinohasama R; Sasano H
    Int J Biol Markers; 2023 Jun; 38(2):105-113. PubMed ID: 37009661
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of clinicopathologic features, survival, and demographics in sebaceous carcinoma patients with and without Muir-Torre syndrome.
    Maloney NJ; Zacher NC; Hirotsu KE; Rajan N; Aasi SZ; Kibbi N
    J Am Acad Dermatol; 2023 Aug; 89(2):269-273. PubMed ID: 37003478
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Effect of Tobacco Smoke
    Doukas SG; Vageli DP; Doukas PG; Nikitovic D; Tsatsakis A; Judson BL
    Curr Oncol; 2022 Aug; 29(8):5531-5549. PubMed ID: 36005175
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNA Methylation by Bisulfite Next-Generation Sequencing for mlh1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field cancerization.
    Padin-Iruegas E; Chamorro-Petronacci CM; Sines-Cajade I; Lorenzo-Pouso AI; Blanco-Carrión A; Pérez-Jardón A; Gándara-Vila P; Pérez-Sayans M
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888599
    [No Abstract]    [Full Text] [Related]  

  • 11. HPV DNA as a Biomarker in Oropharyngeal cancer: A Step in the Right Direction.
    Colevas AD
    Clin Cancer Res; 2022 Oct; 28(19):4171-4172. PubMed ID: 35861851
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
    Hsueh CY; Lau HC; Huang Q; Gong H; Sun J; Cao P; Hu C; Zhang M; Tao L; Zhou L
    Cancer; 2022 Sep; 128(17):3170-3184. PubMed ID: 35789992
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus.
    Pinto R; Hauge T; Jeanmougin M; Pharo HD; Kresse SH; Honne H; Winge SB; Five MB; Kumar T; Mala T; Hauge T; Johnson E; Lind GE
    Clin Epigenetics; 2022 Jun; 14(1):77. PubMed ID: 35701814
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
    Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
    Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Microsatellite Instability Analysis (MSA) for Bladder cancer: Past History and Future Directions.
    Moon C; Gordon M; Moon D; Reynolds T
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884669
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Oral cancer among Khat users: finding evidence from DNA analysis of nine cancer-related gene mutations.
    Alshahrani SA; Al-Qahtani WS; Almufareh NA; Domiaty DM; Albasher GI; Safhi FA; AlQassim FA; Alotaibi MA; Al-Hazani TM; Almutlaq BA
    BMC Oral Health; 2021 Dec; 21(1):626. PubMed ID: 34876124
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Co-Occurrence of Familial Non-Medullary Thyroid cancer (FNMTC) and Hereditary Non-Polyposis Colorectal cancer (hnpcc) Associated Tumors-A Cohort Study.
    Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter.
    Evren B; Yılmaz S; Karadağ N; Sertkaya AÇ; Topaloğlu Ö; Kılınç F
    Sci Rep; 2021 May; 11(1):9932. PubMed ID: 33976347
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. mlh1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Donís SP; González AP; Alves MGO; do Carmo Carvalho BF; Ferreira CCP; Almeida JD; Iruegas EP; Petronacci CMC; Peñaranda JMS; Sayáns MP
    Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):613-618. PubMed ID: 33734109
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
    Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
    ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.